FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for lithium carbonate from Glenmark Pharmaceuticals, approving a supplemental filing related to the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE (LITHIUM CARBONATE)